Streetbeat News

Analyst Ratings

ALNY

CDNS

DIS

DPZ

FFIV

HBAN

HUBS

LULU

PGR

ROP

ZVIA

Several analyst forecasts were released on Tuesday, with price target changes for multiple companies. Notable changes include Needham raising the price target for F5, Inc. (FFIV) from $175 to $180, Barclays raising HubSpot, Inc.'s (HUBS) price target from $425 to $525, and Atlantic Equities cutting The Walt Disney Company's (DIS) price target from $113 to $76. Other companies mentioned include Domino's Pizza, Inc. (DPZ), The Progressive Corporation (PGR), Huntington Bancshares Incorporated (HBAN), Zevia PBC (ZVIA), Roper Technologies, Inc. (ROP), Cadence Design Systems, Inc. (CDNS), Lululemon Athletica Inc. (LULU), and Alnylam Pharmaceuticals, Inc. (ALNY).

Portfolio Pulse from Lisa Levin

July 25, 2023 | 11:51 am

DPZ

RBC Capital analyst Christopher Carril maintains an Outperform rating on Domino's Pizza (NYSE:DPZ) and raises the price target from $430 to $440.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:50 am

ALNY

RBC Capital analyst Luca Issi has maintained an 'Outperform' rating on Alnylam Pharmaceuticals (NASDAQ:ALNY), but lowered the price target from $275 to $270.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:49 am

BABA

Alibaba Group Holding Limited (NYSE:BABA) has been in the spotlight due to its organizational and management restructuring aimed at unlocking shareholder value. The company also received relief from a regulatory crackdown with a final penalty for Ant Group. Alibaba has decided not to reduce its Ant Group stake and reported progress in cutting emissions. The company reinstated Jiang Fan as the international business unit leader. Alibaba's shares traded higher by 1.82% at $98.10 premarket on Tuesday.

Portfolio Pulse from Anusuya Lahiri

July 25, 2023 | 11:48 am

FFIV

F5, Inc. (NASDAQ:FFIV) reported better-than-expected earnings for its third quarter, leading to a 9.9% jump in pre-market trading. The company's Q3 earnings were $3.21 per share, beating estimates of $2.86 per share. F5's Q3 sales were $702.64 million, versus expectations of $699.39 million. Analysts from Keybanc, Needham, and Barclays have raised their price targets on F5 following the earnings announcement.

Portfolio Pulse from Lisa Levin

July 25, 2023 | 11:47 am

RLYB

JMP Securities analyst Jonathan Wolleben has reiterated his 'Market Outperform' rating on Rallybio (NASDAQ:RLYB) and maintained a price target of $16.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:44 am

INCY

JMP Securities analyst Reni Benjamin has reiterated a 'Market Outperform' rating on Incyte (NASDAQ:INCY) and maintained a price target of $93.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:43 am

CVNA

JMP Securities analyst Nicholas Jones has reiterated a 'Market Outperform' rating on Carvana (NYSE:CVNA) and maintained a price target of $60.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:42 am

CRSP

JMP Securities analyst Silvan Tuerkcan has reiterated a Market Outperform rating on CRISPR Therapeutics (NASDAQ:CRSP) and maintained a $74 price target.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:42 am

ACVA

JMP Securities analyst Nicholas Jones has reiterated a Market Outperform rating on ACV Auctions (NASDAQ:ACVA) and maintained a price target of $18.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:41 am